Related Experiment Video
Updated: Jul 11, 2025

A Methodological Approach to Non-invasive Assessments of Vascular Function and Morphology
Published on: February 7, 2015
Beyond Coronary Artery Disease: Assessing the Microcirculation
Sonal Pruthi1, Emaad Siddiqui1, Nathaniel R Smilowitz2
1Division of Cardiology, Department of Medicine, NYU Langone Health, 550 First Avenue, New York, NY 10016, USA.
Insights
Ischemic heart disease (IHD) affects millions, but many patients lack blockages in major arteries. Microvascular angina due to coronary microvascular dysfunction (CMD) is a key cause, highlighting the need for better understanding and treatment of CMD.
Area of Science:
- Cardiology
- Vascular Biology
- Internal Medicine
Background:
- Ischemic heart disease (IHD) impacts over 20 million US adults.
- Atherosclerosis of epicardial coronary arteries is the traditional cause of IHD.
- Nearly half of patients with stable angina and IHD lack obstructive epicardial coronary artery disease.
Purpose of the Study:
- To explore the significance of ischemia with nonobstructive coronary arteries (INOCA).
- To highlight coronary microvascular dysfunction (CMD) as a frequent cause of INOCA and microvascular angina.
- To emphasize the potential of understanding CMD pathophysiology, diagnosis, and treatment for improving IHD patient outcomes.
Main Methods:
- Review of existing literature on IHD, INOCA, and CMD.
- Analysis of clinical data from patients undergoing coronary angiography.
- Pathophysiological and diagnostic approaches to CMD.
Main Results:
- A significant proportion of patients with IHD and angina do not have obstructive epicardial coronary artery disease.
- Coronary microvascular dysfunction (CMD) is a primary driver of microvascular angina in these patients.
- INOCA represents a substantial clinical challenge requiring further investigation.
Conclusions:
- Coronary microvascular dysfunction (CMD) is a critical, often overlooked, contributor to ischemic heart disease.
- Improved understanding and management of CMD are essential for enhancing care for patients with IHD.
- Further research into CMD pathophysiology, diagnosis, and treatment is warranted to improve clinical outcomes.
Abstract:
Ischemic heart disease (IHD) affects more than 20 million adults in the United States. Although classically attributed to atherosclerosis of the epicardial coronary arteries, nearly half of patients with stable angina and IHD who undergo invasive coronary angiography do not have obstructive epicardial coronary artery disease. Ischemia with nonobstructive coronary arteries is frequently caused by microvascular angina with underlying coronary microvascular dysfunction (CMD). Greater understanding the pathophysiology, diagnosis, and treatment of CMD holds promise to improve clinical outcomes of patients with ischemic heart disease.
Related Concept Videos
Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation
Atherosclerosis II: Clinical Manifestations and Diagnostic Tests
Acute Coronary Syndrome III: Diagnostic Studies
Assessment of the Cardiovascular System II: Inspection
Head and Neck

